Skip to main content
. Author manuscript; available in PMC: 2015 Sep 22.
Published in final edited form as: Breast Cancer Res Treat. 2009 Mar 18;117(3):615–623. doi: 10.1007/s10549-009-0366-5

Table 5.

Observed Patient Medication Errors

Events for each of the eight patients who demonstrated overadherence Detection Method
Patient took 2 extra doses gefitinib MEMs
Patient took 5 extra doses gefitinib, also missed a dose of capecitabine, then took extra the following day MEMs
Took extra dose gefitinib, held drug the next day MEMs
Patient missed a dose of capecitabine, then took extra dose the next day MEMs
Patient took multiple extra doses of gefitinib, also had 2 episodes of missing a dose of gefitinib, then taking two the following day. Both
Patient took 3 extra days of capecitabine, took double dose gefitinib once Diary
Patient took extra dose gefitinib in one day, held drug the next day Diary
Patient took 1 extra dose of gefitinib Diary

Caption: Description of the 8 different patients who demonstrated medication errors as part of adherence monitoring. Type of error is described, along with method of detection. Overall adherence rates may not reflect instances of overadherence, as ratios may have been balanced out by missed doses at other times.